Cefotaxime desensitization

Papakonstantinou, G; Bogner, J; Hofmeister, F; Hehlmann, R

dc.contributor.author	Papakonstantinou, G	en
dc.contributor.author	Bogner, J	en
dc.contributor.author	Hofmeister, F	en
dc.contributor.author	Hehlmann, R	en
dc.date.accessioned	2014-03-01T01:41:35Z
dc.date.available	2014-03-01T01:41:35Z
dc.date.issued	1993	en
dc.identifier.uri	https://dspace.lib.ntua.gr/xmlui/handle/123456789/23547
dc.title	Cefotaxime desensitization	en
heal.type	journalArticle	en
heal.identifier.primary	10.1007/BF00180000	en
heal.identifier.secondary	http://dx.doi.org/10.1007/BF00180000	en
heal.publicationDate	1993	en
heal.abstract	We report the successful desensitization to cefotaxime in a patient with severe lumbar osteomyelitis of unknown bacteriology and hypersentivity to the drug. Desensitization was carried out because of the unknown bacteriology, the favorable response to cefotaxime at that time, and hypersensitivity to other antibiotics. On the first day the patient received 1 mg cefotaxime intravenously. The dose was increased for	en
heal.journalName	Journal of Molecular Medicine-jmm	en
dc.identifier.doi	10.1007/BF00180000	en